Infección tuberculosa latente en población indigente. Comparación de dos pautas terapéuticas
- 1 January 2004
- journal article
- clinical trial
- Published by Elsevier in Medicina Clinica
- Vol. 122 (2) , 57-59
- https://doi.org/10.1016/s0025-7753(04)74140-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Safety of 2 Months of Rifampin and Pyrazinamide for Treatment of Latent TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Pyrazinamide and Rifampin vs Isoniazid for the Treatment of Latent TuberculosisChest, 2003
- Short-Course Rifampin and Pyrazinamide Compared with Isoniazid for Latent Tuberculosis Infection: A Multicenter Clinical TrialAnnals of Internal Medicine, 2002
- Acceptability of Short-Course Rifampin and Pyrazinamide Treatment of Latent Tuberculosis Infection Among Jail InmatesChest, 2001
- Targeted Tuberculin Testing and Treatment of Latent Tuberculosis InfectionAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected PersonsAn International Randomized TrialJAMA, 2000
- Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infectionThe Lancet, 1998
- Results of a Directly Observed Intermittent Isoniazid Preventive Therapy Program in a Shelter for Homeless MenAmerican Review of Respiratory Disease, 1992